{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2.505994998"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Participant #1 - Peak percentage of CAR+ cells among peripheral blood mononuclear cells"},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.003513397"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Participant #2 - Peak percentage of CAR+ cells among peripheral blood mononuclear cells"},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.257878064"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Participant #4 - Peak percentage of CAR+ cells among peripheral blood mononuclear cells"},{"categories":[{"measurements":[{"groupId":"OG001","value":"5.692026394"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Participant #5 - Peak percentage of CAR+ cells among peripheral blood mononuclear cells"},{"categories":[{"measurements":[{"groupId":"OG001","value":"0.066168665"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Participant #6 - Peak percentage of CAR+ cells among peripheral blood mononuclear cells"},{"categories":[{"measurements":[{"groupId":"OG001","value":"0.875579553"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Participant #7 - Peak percentage of CAR+ cells among peripheral blood mononuclear cells"},{"categories":[{"measurements":[{"groupId":"OG004","value":"10.425784436"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"1"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Participant #9 - Peak percentage of CAR+ cells among peripheral blood mononuclear cells"},{"categories":[{"measurements":[{"groupId":"OG004","value":"1.173870125"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"1"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Participant 10 - Peak percentage of CAR+ cells among peripheral blood mononuclear cells"},{"categories":[{"measurements":[{"groupId":"OG002","value":"25.06555951"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Participant #11 - Peak percentage of CAR+ cells among peripheral blood mononuclear cells"},{"categories":[{"measurements":[{"groupId":"OG002","value":"2.061723582"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Participant #12 - Peak percentage of CAR+ cells among peripheral blood mononuclear cells"},{"categories":[{"measurements":[{"groupId":"OG002","value":"0.951813793"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Participant #13 - Peak percentage of CAR+ cells among peripheral blood mononuclear cells"},{"categories":[{"measurements":[{"groupId":"OG002","value":"3.770199852"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Participant 14 - Peak percentage of CAR+ cells among peripheral blood mononuclear cells"},{"categories":[{"measurements":[{"groupId":"OG002","value":"21.6416809"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Participant #15 - Peak percentage of CAR+ cells among peripheral blood mononuclear cells"},{"categories":[{"measurements":[{"groupId":"OG004","value":"9.701843954"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"1"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Participant #17 - Peak percentage of CAR+ cells among peripheral blood mononuclear cells"},{"categories":[{"measurements":[{"groupId":"OG002","value":"6.193353177"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Participant #18 - Peak percentage of CAR+ cells among peripheral blood mononuclear cells"},{"categories":[{"measurements":[{"comment":"As pre-specified by the protocol a participant must receive cells to measure percentage and persistence at 1 month. Participant did not receive CAR T cells, so no CAR T cells could possibly be detected in the blood.","groupId":"OG005","value":"NA"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"1"}],"units":"Participants"}],"title":"Participant #19 - Peak percentage of CAR+ cells among peripheral blood mononuclear cells"},{"categories":[{"measurements":[{"groupId":"OG003","value":"3.484185735"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Participant #20 - Peak percentage of CAR+ cells among peripheral blood mononuclear cells"},{"categories":[{"measurements":[{"groupId":"OG003","value":"51.30355798"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Participant #21 - Peak percentage of CAR+ cells among peripheral blood mononuclear cells"},{"categories":[{"measurements":[{"groupId":"OG003","value":"29.40752103"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Participant #22 - Peak percentage of CAR+ cells among peripheral blood mononuclear cells"},{"categories":[{"measurements":[{"groupId":"OG003","value":"22.45790377"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Participant #24 - Peak percentage of CAR+ cells among peripheral blood mononuclear cells"},{"categories":[{"measurements":[{"groupId":"OG003","value":"55.04760657"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Participant #25 - Peak percentage of CAR+ cells among peripheral blood mononuclear cells"},{"categories":[{"measurements":[{"groupId":"OG002","value":"25.56426658"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Participant #26 - Peak percentage of CAR+ cells among peripheral blood mononuclear cells"},{"categories":[{"measurements":[{"comment":"Below the level of detection.","groupId":"OG000","value":"NA"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Participant #1 - %CAR+ cells among peripheral blood mononuclear cells 1 month after infusion"},{"categories":[{"measurements":[{"comment":"Below the level of detection.","groupId":"OG000","value":"NA"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Participant #2 - %CAR+ cells among peripheral blood mononuclear cells 1 month after infusion"},{"categories":[{"measurements":[{"comment":"Sample not available (participant 4 did not have blood drawn at the 1 month f/u due to not coming to their visit).","groupId":"OG000","value":"NA"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Participant #4 - %CAR+ cells among peripheral blood mononuclear cells 1 month after infusion"},{"categories":[{"measurements":[{"groupId":"OG001","value":"0.036582556"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Participant #5 - %CAR+ cells among peripheral blood mononuclear cells 1 month after infusion"},{"categories":[{"measurements":[{"groupId":"OG001","value":"0.010607229"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Participant #6 - %CAR+ cells among peripheral blood mononuclear cells 1 month after infusion"},{"categories":[{"measurements":[{"groupId":"OG001","value":"0.002843526"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Participant #7 - %CAR+ cells among peripheral blood mononuclear cells 1 month after infusion"},{"categories":[{"measurements":[{"groupId":"OG004","value":"0.145937491"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"1"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Participant #9 - %CAR+ cells among peripheral blood mononuclear cells 1 month after infusion"},{"categories":[{"measurements":[{"groupId":"OG004","value":"0.006382466"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"1"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"#10 - %CAR+ cells among peripheral blood mononuclear cells 1 month after infusion"},{"categories":[{"measurements":[{"comment":"Sample not available. Participant 11's CAR T cell blood level could not be determined due to technical problems with the research blood sample.","groupId":"OG002","value":"NA"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Participant #11 - %CAR+ cells among peripheral blood mononuclear cells 1 month after infusion"},{"categories":[{"measurements":[{"groupId":"OG002","value":"2.061723582"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Participant #12 - %CAR+ cells among peripheral blood mononuclear cells 1 month after infusion"},{"categories":[{"measurements":[{"comment":"Below the level of detection.","groupId":"OG002","value":"NA"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Participant #13 - %CAR+ cells among peripheral blood mononuclear cells 1 month after infusion"},{"categories":[{"measurements":[{"groupId":"OG002","value":"2.361884069"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Participant #14 - %CAR+ cells among peripheral blood mononuclear cells 1 month after infusion"},{"categories":[{"measurements":[{"groupId":"OG002","value":"1.584343701"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Participant #15 - %CAR+ cells among peripheral blood mononuclear cells 1 month after infusion"},{"categories":[{"measurements":[{"groupId":"OG004","value":"0.09701347"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"1"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Participant #17 - %CAR+ cells among peripheral blood mononuclear cells 1 month after infusion"},{"categories":[{"measurements":[{"groupId":"OG002","value":"6.193353177"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Participant #18 - %CAR+ cells among peripheral blood mononuclear cells 1 month after infusion"},{"categories":[{"measurements":[{"comment":"As pre-specified by the protocol a participant must receive cells to measure percentage and persistence at 1 month. Participant did not receive CAR T cells, so no CAR T cells could possibly be detected in the blood.","groupId":"OG005","value":"NA"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"1"}],"units":"Participants"}],"title":"Participants #19 - %CAR+ cells among peripheral blood mononuclear cells 1 month after infusion"},{"categories":[{"measurements":[{"groupId":"OG003","value":"1.110480727"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Participant #20 - %CAR+ cells among peripheral blood mononuclear cells 1 month after infusion"},{"categories":[{"measurements":[{"groupId":"OG003","value":"8.51303351"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Participant #21 - %CAR+ cells among peripheral blood mononuclear cells 1 month after infusion"},{"categories":[{"measurements":[{"groupId":"OG003","value":"11.65873475"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Participant #22 - %CAR+ cells among peripheral blood mononuclear cells 1 month after infusion"},{"categories":[{"measurements":[{"groupId":"OG003","value":"0.289276145"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Participant #24 - %CAR+ cells among peripheral blood mononuclear cells 1 month after infusion"},{"categories":[{"measurements":[{"groupId":"OG003","value":"18.33580648"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Participant #25 - %CAR+ cells among peripheral blood mononuclear cells 1 month after infusion"},{"categories":[{"measurements":[{"comment":"Sample not available (participant 26 did not have blood drawn at the 1 month f/u due to not coming to their visit).","groupId":"OG002","value":"NA"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Participant #26 - %CAR+ cells among peripheral blood mononuclear cells 1 month after infusion"}],"denoms":[{"counts":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"7"},{"groupId":"OG003","value":"5"},{"groupId":"OG004","value":"3"},{"groupId":"OG005","value":"1"}],"units":"Participants"}],"description":"Peak percentage and the percentage 1 month after infusion of peripheral blood mononuclear cells (PBMC) that expressed the Chimeric Antigen Receptor (CAR) T-cells assessed by polymerase chain reaction (PCR).","groups":[{"description":"Participants who have not had an allogeneic hematopoietic stem cell transplant. 0.3x10\\^6 Chimeric Antigen Receptor (CAR) T cells per kg of recipient bodyweight\n\nStarting dose: 0.3x10\\^6 Chimeric Antigen Receptor (CAR)+ T cells/kg (weight based dosing) infuse on day 0 and Cyclophosphamide: 300 mg/m\\^2 intravenous (IV) infusion over 30 minutes on days -5, -4 and -3 and Fludarabine: 30 mg/m\\^2 IV infusion over 30 minutes administered immediately following the cyclophosphamide on days -5, -4, and -3","id":"OG000","title":"Dose Escalation Cohort 1 Dose Level 1 - 0.3x10^6 Chimeric Antigen Receptor (CAR) T Cells Per kg"},{"description":"Participants who have not had an allogeneic hematopoietic stem cell transplant. 1.0x10\\^6 Chimeric Antigen Receptor (CAR) T cells per kg of recipient bodyweight\n\n1.0x10\\^6 Chimeric Antigen Receptor (CAR)+ T cells/kg (weight based dosing) infuse on day 0 and Cyclophosphamide: 300 mg/m\\^2 intravenous (IV) infusion over 30 minutes on days -5, -4 and -3 and Fludarabine: 30 mg/m\\^2 IV infusion over 30 minutes administered immediately following the cyclophosphamide on days -5, -4, and -3","id":"OG001","title":"Dose Escalation Cohort 1 Dose Level 2 - 1.0x10^6 Chimeric Antigen Receptor (CAR) T Cells Per kg"},{"description":"Participants who have not had an allogeneic hematopoietic stem cell transplant. 3.0x10\\^6 Chimeric Antigen Receptor (CAR) T cells per kg of recipient bodyweight\n\n3.0x10\\^6 Chimeric Antigen Receptor (CAR)+ T cells/kg (weight based dosing) infuse on day 0 and Cyclophosphamide: This chemotherapy dose was changed part-way through the protocol, thus 4 participants received 500 mg/m\\^2 and 3 participants received 300 mg/m\\^2 intravenous (IV) infusion over 30 minutes on days -5, -4 and -3 and Fludarabine: 30 mg/m\\^2 IV infusion over 30 minutes administered immediately following the cyclophosphamide on days -5, -4, and -3.","id":"OG002","title":"Dose Escalation Cohort 1 Dose Level 3 - 3.0x10^6 Chimeric Antigen Receptor (CAR) T Cells Per kg"},{"description":"Participants who have not had an allogeneic hematopoietic stem cell transplant. 9.0x10\\^6 Chimeric Antigen Receptor (CAR) T cells per kg of recipient bodyweight\n\n9.0x10\\^6 Chimeric Antigen Receptor (CAR)+ T cells/kg (weight based dosing) infuse on day 0 and Cyclophosphamide: 500 mg/m\\^2 intravenous (IV) infusion over 30 minutes on days -5, -4 and -3 and Fludarabine: 30 mg/m\\^2 IV infusion over 30 minutes administered immediately following the cyclophosphamide on days -5, -4, and -3","id":"OG003","title":"Dose Escalation Cohort 1 Dose Level 4 - 9.0x10^6 Chimeric Antigen Receptor (CAR) T Cells Per kg"},{"description":"Participants who have had an Human Leukocyte Antigen (HLA)-matched sibling or an 8/8-HLA-matched unrelated donor transplant.\n\n0.3x10\\^6 Chimeric Antigen Receptor (CAR) T cells per kg of recipient bodyweight\n\n0.3 x10\\^6 Chimeric Antigen Receptor (CAR)+ T cells/kg (weight based dosing) infuse on day 0 and Cyclophosphamide: 300 mg/m\\^2 intravenous (IV) infusion over 30 minutes on days -5, -4 and -3 and Fludarabine: 30 mg/m\\^2 IV infusion over 30 minutes administered immediately following the cyclophosphamide on days -5, -4, and -3","id":"OG004","title":"Dose Escalation Cohort 2 Dose Level 1 - 0.3x10^6 Chimeric Antigen Receptor (CAR) T Cells Per kg"},{"description":"Participants who have had an Human Leukocyte Antigen (HLA)-matched sibling or an 8/8 HLA-matched unrelated donor transplant.\n\n1.0x10\\^6 Chimeric Antigen Receptor (CAR) T cells per kg of recipient bodyweight\n\n1.0x10\\^6 Chimeric Antigen Receptor (CAR)+ T cells/kg (weight based dosing) infuse on day 0 and Cyclophosphamide: 300 mg/m\\^2 intravenous (IV) infusion over 30 minutes on days -5, -4 and -3 and Fludarabine: 30 mg/m\\^2 IV infusion over 30 minutes administered immediately following the cyclophosphamide on days -5, -4, and -3","id":"OG005","title":"Dose Escalation Cohort 2 Dose Level 2 - 1.0x10^6 Chimeric Antigen Receptor (CAR) T Cells Per kg"}],"paramType":"NUMBER","populationDescription":"Participants #8, and 23 were not assigned to a dose level since they didn't receive chemo or cells. Participant # 5 first enrolled as #3 did not result in cell infusion and was re-enrolled with a new number for cell infusion. This is the same for #18 who was first enrolled as #16.","reportingStatus":"POSTED","timeFrame":"From time of infusion until 1 month after infusion","title":"Peak Percentage and Persistence at 1 Month of Peripheral Blood Mononuclear Cells (PBMC) That Expressed the Chimeric Antigen Receptor (CAR) T-cells","type":"SECONDARY","unitOfMeasure":"peak percentage"}